Score Breakdown
Offering Ability
37
Cash Runway
95
Float Risk
4
Warrant Exposure
50
Convertible Debt
15
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 54%
🔄 Reverse Split
model est. 70%
• 50-day avg $0.04 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise
model 55%
• Critical: only 0.4 months cash remaining
📜 Warrant Exercise
model 15%
• Warrant overhang: 13.4% of shares outstanding
Market Data
Market Cap$3.63M
Shares Outstanding114.70M
Float113.48M
Cash$23.4K
Debt$48.1K
Short InterestN/A
Institutional Holdings
Institutional data not yet available.
Short Interest
Short Interest15.0K
Days to Cover1.0
% of Float0.0%
FINRA data as of Jul 15, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2026-06-30
8-K
8K EVENT
2026-03-20
8-K
8K EVENT
2026-03-13
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual BIXT Dilution Snapshot
Bioxytran, Inc. (BIXT) has a DilutionScore of 65/100, rated High dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 15.4M.
- Recent SEC activity tracked for BIXT: xbrl on 2026-06-30; xbrl on 2026-06-30; 8-K on 2026-03-20.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: